FDA Approvals - FDA Approves DORIBAX(TM) For The Treatment Of Complicated Intra-Abdominal And
FDA Approves DORIBAX(TM) For The Treatment Of Complicated Intra-Abdominal And Complicated Urinary Tract Infections (Medical News Today)
The U.S. Food and Drug Administration (FDA) has approved DORIBAX(TM) (doripenem for injection) as a new treatment for complicated intra-abdominal and complicated urinary tract infections, including pyelonephritis. DORIBAX has demonstrated activity against a wide range of Gram-positive(1) and Gram-negative(2) bacteria -- including Pseudomonas -- that cause these serious infections. [click link ...
Teleflex Announces that Arrow International has Received FDA Corporate Warning Letter (Business Wire via Yahoo! Finance)
LIMERICK, Pa.----Teleflex Incorporated today announced that its subsidiary, Arrow International has received a corporate warning letter from the Philadelphia District Office of the U.S.